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Abstract. 
 
Bronchial smooth muscle (SM) mesenchy-
mal cell precursors change their shape from round to 
spread/elongated while undergoing differentiation. 
Here we show that this change in cell shape induces the 
 
expression of laminin (LM) 
 
a
 
2 chain not present in 
round mesenchymal cells. LM 
 
a
 
2 expression is revers-
ible and switched on and off by altering the cell’s shape 
in culture. In comparison, the expression of LM 
 
b
 
1 and 
 
g
 
1 remains unchanged. Functional studies showed that 
mesenchymal cell spreading and further differentiation 
into SM are inhibited by an antibody against LM 
 
a
 
2. 
 
Dy/dy
 
 mice express very low levels of LM 
 
a
 
2 and ex-
hibit congenital muscular dystrophy. Lung SM cells iso-
lated from adult 
 
dy/dy
 
 mice spread defectively and syn-
thesized less SM 
 
a
 
-actin, desmin, and SM-myosin than 
controls. These deﬁciencies were completely corrected 
by exogenous LM-2. On histological examination,
 
dy/dy
 
 mouse airways and gastrointestinal tract had 
shorter SM cells, and lungs from 
 
dy/dy
 
 mice contained 
less SM-speciﬁc protein. The intestine, however, 
showed compensatory hyperplasia, perhaps related to 
its higher contractile activity. This study therefore dem-
onstrated a novel role for the LM 
 
a
 
2 chain in SM myo-
genesis and showed that its decrease in 
 
dy/dy
 
 mice re-
sults in abnormal SM.
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L
 
AMININS
 
 (LMs)
 
1
 
 are heterotrimeric basement mem-
brane glycoproteins composed of 
 
a
 
, 
 
b
 
 and 
 
g
 
 chains
linked together by disulfide bonds in a cruciform
tertiary structure. The first LM identified, referred to as
LM-1, is composed of 
 
a
 
1, 
 
b
 
1, and 
 
g
 
1 chains (Timpl et al.,
1979; Burgeson et al., 1994). LM-2, also known as merosin,
was isolated as a protein present in basement membranes
of human placenta (Leivo and Engvall, 1988) and is com-
posed of 
 
a
 
2, 
 
b
 
1, and 
 
g
 
1 chains (Burgeson et al., 1994). In
addition to forming part of LM-2, LM 
 
a
 
2 chain binds co-
valently to LM 
 
b
 
2 and 
 
g
 
1 chains to form LM-4 (Burgeson
et al., 1994). LM-2 is the predominant isoform in striated
muscle fiber basement membranes and is essential for
skeletal muscle development and stability (Vachon et al.,
1996).
The human LM 
 
a
 
2 chain gene (Lama2) was localized to
chromosome 6q22-23 (Vuolteenaho et al., 1994). Muta-
tions in the LM 
 
a
 
2 chain gene cause autosomal recessive
 
congenital muscular dystrophies in humans and in 
 
dy/dy
 
mice (Hillaire et al., 1994;
 
 
 
Sunada et al., 1994; Xu et al.,
1994a,b). These mutations result in very low levels of nor-
mal LM 
 
a
 
2 chain (Sunada et al., 1994; Xu et al., 1994b), or
in synthesis of truncated chains (Xu et al., 1994a) which in
turn lead to severely defective muscle basement mem-
branes (Xu et al., 1994b). Knockout of the LM 
 
a
 
2 chain
gene in mice by homologous recombination has confirmed
its importance in skeletal muscle development and func-
tion (Miyagoe et al., 1997).
The laminin 
 
a
 
2 chain is expressed in the developing and
adult human and mouse lung (Vuolteenaho et al., 1994;
Bernier et al., 1995; Virtanen et al., 1996; Miner et al.,
1997; Schuger et al., 1997; Flores-Delgado et al., 1998) and
it is deposited in the bronchial epithelial basement mem-
brane and adjacent to the peribronchial mesenchymal cells
(Virtanen et al., 1996; Wu and Santoro, 1996; N. Relan and
L. Schuger, unpublished observations). During lung devel-
opment, its expression lags that of the LM 
 
a
 
1 chain and
coincides with the period of active bronchial myogenesis
(Virtanen et al., 1996). The functional role of LM 
 
a
 
2 chain
in the developing lung has not been elucidated, although it
has been shown to facilitate attachment of lung myofibro-
blasts in culture (Flores-Delgado et al., 1998).
During development, embryonic cells undergo signifi-
cant changes in shape, starting as round pluripotent cells
and culminating in the multiple cellular configurations
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seen in mature tissues. Our studies (Schuger et al., 1997;
Yang et al., 1998, 1999) as well as others (Leptin, 1995;
Loty et al., 1995; Anastasi et al., 1997; Fernandez-Valle
et al., 1997; Martin-Blanco, 1997, 1998; Bidwell et al.,
1998) indicate that these changes in cell shape play an ac-
tive role in the mechanistic pathways determining cell dif-
ferentiation. Among the multiple factors potentially con-
trolling cell shape, we identified LM-1 as relevant for
bronchial myogenesis (Schuger et al., 1997; Yang et al.,
1998). More specifically, we determined that cell spread-
ing/elongation is essential for inducing SM differentiation
(Yang et al., 1998, 1999) and that this change in cell shape
is stimulated by LM 
 
a
 
1 chain deposition and further poly-
merization at the airway basement membrane site (Schu-
ger et al., 1997; Yang et al., 1998).
Here we show that cell spreading/elongation, whether in
vivo or in vitro, activates expression of the LM 
 
a
 
2 chain,
which is absent in round cells. In addition, by blocking LM
 
a
 
2 with a specific antibody, we demonstrate that, once se-
creted, LM 
 
a
 
2 promotes mesenchymal cell spreading/elon-
gation and further SM myogenic differentiation. Our find-
ings thus provide a potential explanation for how SM
myogenesis could proceed after LM-1 in the epithelial
basement membrane stimulates the first layer of mesen-
chymal cells to elongate and differentiate.
Since 
 
dy/dy
 
 mice express low levels of LM 
 
a
 
2 chain, we
used their cells to further study the role of this LM chain in
myogenesis. Here we show that lung mesenchymal cells
isolated from 
 
dy/dy
 
 mice spread defectively in culture and
synthesize less SM 
 
a
 
-
 
actin, desmin and SM myosin than
controls. These abnormalities were completely overcome
by the addition of exogenous LM-2. Furthermore, histo-
logical examination of 
 
dy/dy
 
 mouse tissues revealed subtle
but diffuse SM cell shortening that, in the absence of com-
pensatory muscle hyperplasia, resulted in lower levels of
SM-specific proteins in immunoblots. Our studies there-
fore demonstrate a novel role for LM 
 
a
 
2 chain in visceral
myogenesis. Its regulation by cell shape may contribute to
a multilayered bronchial SM, and its absence may cause
abnormal visceral muscle.
 
Materials and Methods
 
LMs and Antibodies
 
LM-1 from the mouse EHS tumor, type IV collagen, and fibronectin were
purchased from Becton-Dickinson, and LM-2 was obtained from GIBCO
BRL. A polyclonal rat antibody to EHS LM which recognizes LM 
 
a
 
1, 
 
a
 
2,
and 
 
b
 
1/
 
g
 
1 chains (LM-1/LM-2) (Schuger et al., 1997), was a gift from Dr.
Amy Skubitz (University of Minnesota, Minneapolis, MN). A rat mono-
clonal antibody to the NH
 
2
 
 terminus of mouse LM 
 
a
 
2 chain (Schuler and
Sorokin, 1995) was obtained from Alexis Inc. A mouse monoclonal anti-
body to SM 
 
a
 
-actin was obtained from Boehringer Mannheim, rabbit
polyclonal antibodies to SM myosin were purchased from Biomedical
Technologies, and a mouse monoclonal antibody to desmin was pur-
chased from Dako (Carpinteria, CA). HRP-labeled secondary antibodies
were purchased from Bio-Rad and normal rat IgG was purchased from
Cappel.
 
Cells and Lung Fragments
 
To obtain embryonic mesenchymal cells, Crl: CD-1
 
®
 
 (ICR) BR mice
(Charles River) were mated and the day of finding a vaginal plug was des-
ignated as day zero of embryonic development. Lungs were removed at
days 12–15 of gestation, minced, and then trypzinised into a single cell sus-
pension, and the mesenchymal cells were isolated by differential plating as
 
previously described (Schuger et al., 1993). The cells were directly cul-
tured under conditions that promoted either cell rounding or cell spread-
ing/elongation. The cell’s shape was controlled by means of three different
cell culture systems: (a) mesenchymal cells were plated on 10- or 20-
 
m
 
m-
diam culture microsurfaces, the first to force cell rounding and the second
to allow cell spreading/elongation (Yang et al., 1999). (b) Mesenchymal
cells were plated on culture dishes pretreated with 0.05% poly-
 
L
 
-lysine or
0.05% poly-
 
L
 
-lysine was added to the cultures after cell spreading/elonga-
tion was completed, the first to force cell rounding and the second to allow
cell spreading/elongation (Yang et al., 1998). (c) Mesenchymal cells were
plated in untreated culture dishes at high density or at subconfluent densi-
ties without further treatment, the first to force cell rounding and the sec-
ond to allow cell spreading (Yang et al., 1998). In some experiments, after
24 h in culture, the cells were switched from conditions that promoted cell
rounding to conditions that promoted cell spreading/elongation and vice
versa. In these cases all the cells were trypsinized after an additional 24 h
in culture. Surface-anchored epithelial-mesenchymal cocultures (organo-
typic) were generated by plating at high density (2–4 
 
3
 
 10
 
6
 
/ml) a mixture
of epithelial and mesenchymal cells isolated from embryonic lungs
(Schuger et al., 1995). Lung embryonic epithelial cells and intestine and
kidney embryonic mesenchymal cells were used in some studies. These
were also isolated by differential plating (Schuger et al., 1993) and cul-
tured under conditions that promote cell rounding or cell elongation. To
obtain adult mesenchymal cells, the lungs of adult CD-1 mice, C57BL/6J
 
dy/dy
 
 mice, or C57BL/6J 
 
1
 
/
 
1
 
 normal mice (both from Jackson Immu-
noResearch Laboratories) were minced in 0.1% collagenase and incu-
bated at 37
 
8
 
C for 60 min. Single cell suspensions were obtained and cul-
tures of round or spread/elongated mesenchymal cells were generated as
described above. All the cultures were incubated in MEM with nonessen-
tial amino acids, 0.29 
 
m
 
g/ml 
 
L
 
-glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml
streptomycin, 0.25 
 
m
 
g/ml amphotericin B, and 10% fetal bovine serum.
In some studies, tissues were isolated from the embryo, immediately
lysed, and used for immunoblot analysis. Whole lungs were microdis-
sected from day 10–10.5 mouse embryos. Fragments of undifferentiated,
round mesenchymal cells were microdissected from the periphery of day
12 mouse embryonic lungs, and fragments of elongated mesenchymal cells
were microdissected, together with epithelial cells, from the proximal/cen-
tral part of day 12 lungs.
 
Immunoblotting and Immunoprecipitation
 
Cells and tissues from CD-1, C57BL/6J 
 
dy/dy
 
 mice and C57BL/6J 
 
1
 
/
 
1
 
normal mice were lysed and resolved under reducing conditions by
PAGE. Immunoblotting for LMs and SM proteins was then done as de-
scribed (Schuger et al., 1997; Yang et al., 1998, 1999). For immunoprecipi-
tation studies the cells were lysed and 50 
 
m
 
g of sample were cleared with
protein A–conjugated sepharose (Sigma) and immunoprecipitated with 1 
 
m
 
g
of monoclonal antibody against LM 
 
a
 
2 chain for 16–24 h at 4
 
8
 
C in a rotary
shaker. The immune complex was precipitated with protein A–conjugated
Sepharose and resolved by 3.5% PAGE. The samples were transferred to
nitrocellulose membranes and blotted with polyclonal antibody to LM-1/
LM-2 (1:100 dilution) and bands were detected by chemiluminescence as
previously described (Schuger et al., 1997).
 
RT-PCR and Ribonuclease Protection Assay
 
Mesenchymal cell cultures were briefly washed with PBS, lysed with Tri-
zol (GIBCO BRL) and total RNA was extracted and used for RT-PCR
and ribonuclease protection assay (RPA). RT-PCR was performed with
the GeneAmp
 
®
 
 RNA PCR kit (Perkin Elmer) following the manufac-
turer’s instructions. 25 cycles were run for amplification of 
 
b
 
1 and 
 
g
 
1
chains and 30 for amplification of 
 
a
 
1, 
 
a
 
2 chains, 
 
a
 
4 and 
 
a
 
5 chains. The fol-
lowing primers were used for PCR: LM 
 
a
 
1 chain 5
 
9
 
 forward primer: 5
 
9
 
-
tgggtgtgggatttcttagc-3
 
9
 
 and 3
 
9
 
 reverse primer: 5
 
9
 
-cctgaccgtctacccagtgt-3
 
9
 
,
LM 
 
a
 
2 chain 5
 
9
 
 forward primer: 5
 
9
 
-gcctgccaactctgagaaac-3
 
9
 
 and 3
 
9
 
 reverse
primer: 5
 
9
 
-tcccaagagaatgatcccag-3
 
9
 
, LM 
 
a
 
4 chain 5
 
9
 
 forward primer: 5
 
9
 
-gcc-
atcgaagaagtagctgg-3
 
9
 
 and 3
 
9
 
-reverse primer: 5
 
9
 
-cccctgaggacactgtgttt-3
 
9
 
,
LM 
 
a
 
5 chain 5
 
9
 
 forward primer: 5
 
9
 
-tgaaggcagagggtagcagt-3
 
9
 
 and 3
 
9
 
 reverse
primer 5
 
9
 
-gttgtctgcctggcttcttc-3
 
9
 
, LM 
 
b
 
1 chain 5
 
9
 
 forward primer: 5
 
9
 
-gttc-
gagggaactgcttctg-3
 
9
 
 and 3
 
9
 
 reverse primer: 5
 
9
 
-tgccagtagccaggaagact-3
 
9
 
. LM
 
g
 
1 chain 5
 
9
 
 forward primer: 5
 
9
 
-gagctttgaggacgaccttg-3
 
9
 
 and 39 reverse
primer 59-ctggggtgtgtatgctgatg-39.
For RPA a 356-bp LM a2 chain fragment which was cloned in the pCR
II vector (Miner et al., 1997) was linearized and transcribed in vitro using
the MAXIscript kit (Ambion Inc.) and UTP a-[32P] (400–900 Ci/mmol
and 10 mCi/ml; NEN). The hybridization was carried out using an RPARelan et al. Cell Elongation and Laminin a2: Role in Myogenesis 1343
kit (Ambion Inc.) and following the manufacturer’s instructions. A 256-bp
GAPDH linearized fragment obtained from Ambion Inc. was used as a
control. The protected RNA fragments were resolved on a 5% denaturing
polyacrylamide gel and autoradiographed.
Cell Attachment and Spreading Assays
Freshly isolated lung mesenchymal cells were cultured in the presence of
anti-LM a2 chain antibody, anti-LM a2 chain antibody preincubated with
10-fold excess of LM-2 (molar:molar) or IgG control. The antibody and
IgG were added at concentrations of 1, 2, 5, and 10 mg/ml to the cultures
either at the time of cell plating to determine their effect on cell attach-
ment or 40 min after plating, when attachment was completed, to deter-
mine their effect on cell spreading. The cultures were maintained for 2
and 4 h for cell attachment studies and for 4 and 24 h for cell spreading
studies. At the end of the culture period the cells were either fixed or
lysed. Fixed cells were counted and their diameters were determined on
images projected on a computer screen with the aid of a digitized pad and
the image analysis program Optimas 5.1. (Schuger et al., 1995). Statistical
significance was determined by the Student’s t test. Lysed cells were used
for immunoblotting with anti-SM a actin, anti-desmin and anti-SM myosin
antibodies as described above. In additional experiments mesenchymal
cells were isolated from adult C57BL/6J dy/dy and C57BL/6J 1/1 normal
mice and plated on culture dishes uncoated or coated with 10 mg/ml of
LM-2 as indicated in the manufacturer’s instructions for cell attachment
assays or with the same concentration of LM-1 or fibronectin. Cell attach-
ment and spreading was then determined as just described.
Histological Studies
Lungs with trachea, stomach, and intestine from adult C57BL/6J dy/dy,
C57BL/6J 1/1 normal mice and CD-1 mice were formalin-fixed and par-
affin-embedded. 5-mm sections were mounted on glass slides and stained
with hematoxilin-eosin for light microscopic examination. Since the nuclei
of SM cells are proportional to the cell’s length and the cell boundaries are
indistinct in vivo, nuclear length was determined as an indicator of cell
elongation. Up to 460 nuclei (lung, 216; stomach, 120; intestine, 124 nu-
clei) were measured as described above in sections from lung, stomach,
and intestine dissected from four dy/dy, four C57BL/6J 1/1 and two
CD-1 mice.
Immunohistochemistry
Mesenchymal cell cultures and organotypic epithelial-mesenchymal cocul-
tures were immunostained with anti-LM a2 antibodies and frozen sections
from dy/dy and normal lungs were immunostained with anti-SM a-actin
following previous protocols (Schuger et al., 1997; Yang et al., 1998). Both
antibodies were used at a concentration of 1 mg/ml. The corresponding
secondary antibodies were used at a 1:50 dilution and the immunostaining
was completed using a commercial peroxidase-anti-peroxidase kit (Dako),
following the manufacturer’s instructions. Fast red (red color) was used
for detecting LM a2 and diaminobenzidine tetrahydrochloride (DAB)
(brown color) was used for detecting SM a actin.
Results
LM a2 chain expression is prevented by cell rounding and
is induced by cell spreading/elongation. Regardless of the
culture system used to facilitate cell rounding or cell
spreading, we consistently observed that only spread cells
expressed LM a2 chain. Immunoblots of round and elon-
gated lung mesenchymal cells plated on culture microsur-
faces showed LM a2 chain as a protein with a Mr of z350
kD present only in lysates from elongated cells (Fig. 1 A).
The band was not detected during the first 4 h in culture,
but progressively appeared within the next 20 h. Unlike
the LM a2 chain, no modulations were found in expres-
sion of the LM b1 and g1 chains, which was similar for
both round and elongated cells. We used a monospecific
antibody to confirm the identity of LM a2 chain. Since this
antibody is not suited for immunoblotting, we used it for
immunoprecipitation, followed by immunoblotting with
the anti–LM-1/LM-2 antibody mentioned above. The lack
of LM-2 in the round cell immunoprecipitates confirmed
that only elongated cells synthesize LM a2 (Fig. 1 B).
RT-PCR and RPAs demonstrated that the increment in
LM a2 chain is, at least in part, the result of an increment
in its steady-state mRNA levels (Fig. 1 C). RT-PCR dem-
onstrated no changes in mRNA levels for LM a1, b1, and
g1 chains between round and elongated cells as well as no
changes in LM a4 and a5 message levels (not shown). As
expected, LM a1 polypeptide chain was not detected un-
der any of these culture conditions. Our previous studies
showed that LM a1 chain synthesis requires epithelial-
mesenchymal cell–cell contact (Schuger et al., 1997). No
differences were seen in cell spreading and LM a2 chain
synthesis between cells plated on uncoated dishes or
dishes coated with LM-1, LM-2, collagen IV, and fibronec-
tin (not shown).
Immunohistochemical studies confirmed the absence of
LM a2 chain in round mesenchymal cells and its presence
in elongated cells (Fig. 2, A–C). In organotypic cultures
epithelial cells rearrange into spheres and mesenchy-
Figure 1. LM a2 chain expression in round versus elongated lung
mesenchymal cells. (A) Western blot using a polyclonal antibody
to LM-1/LM-2 on cells cultured for 4 and 24 h on 10- (R, round)
or 20-mm microsurfaces (E, elongated). Note the presence of LM
a2 band in elongated cells (E) after 24 h of culture. LM a2 also
appears in the culture media after 24 h of culture. The first lane is
LM-1 from the EHS tumor, used as control. (B) Cell lysates from
round (R) and elongated (E) mesenchymal cells were immuno-
precipitated with a monoclonal antibody against LM a2 chain
and blotted with a polyclonal antibody to LM-1/LM-2. The im-
munoblot shows that the elongated cells but not the round cells
synthesize trimeric LM-2. (C) RT-PCR showing higher levels of
LM a2 chain mRNA in elongated (E), compared with round cells
(R) (30 PCR cycles for a1 and b1 chains, 25 cycles for b1 and g1
chains). (D) RPA confirming the higher level of LM a2 chain
mRNA in elongated (E) cells.The Journal of Cell Biology, Volume 147, 1999 1344
mal cells surround them forming also a surface-anchored
monolayer (Schuger et al., 1993). A basement membrane
is the novo assembled at the epithelial-mesenchymal in-
terface (Schuger et al., 1998). The mesenchymal cells
apposed to this new basement membrane elongate and
become SM cells, while the rest remain round and undif-
ferentiated (Yang et al., 1998). The elongated cells synthe-
sized LM a2, whereas the rest remained negative (Fig. 2
D). Over time the mesenchymal cells formed cysts with
central lumens and additional mesenchymal cells spread/
elongated around them and synthesized LM a2 chain (Fig.
2, inset).
In vivo undifferentiated (round) mesenchymal cells do
not express LM a2 chain, but elongated cells do. Here we
determined whether the observations made in tissue cul-
tures were relevant to the lung in vivo. At day 10.5 of ges-
tation all the cells in the lung are round in shape. At this
stage, the embryonic lung synthesizes LM a1 but not LM
a2 (Fig. 3, first lane). At day 12 of gestation, most of the
proximal peribronchial mesenchymal cells become spread/
elongated and the distal epithelial cells become spread/
flat. The undifferentiated mesenchymal cells, however, are
still round. Western blots of microdissected airways and
surrounding mesenchyme showed that the elongated cells
express both LM a1 and a2 chains (Fig. 3, second lane),
whereas Western blots of microdissected undifferentiated
mesenchyme showed absence of LM a2 chains in round
cells (Fig. 3, third lane).
LM a2 chain expression is turned on and off by changes
in cell shape. Switching cells from culture conditions that
promote cell rounding to culture conditions that promote
cell elongation and vice versa demonstrated that synthesis
of LM a2 chain can be switched on and off by changes in
cell shape (Fig. 4). Replating efficiency was similar for
Figure 2. Immunohistochemical detection
of LM a2 chain in round and elongated
cells in monocultures and in organotypic
epithelial-mesenchymal cocultures. (A)
mouse mesenchymal cells cultured for 24 h
in 0.05% poly-L-lysine coated dishes re-
main round and negative for LM a2 chain.
(B) Mesenchymal cells plated at high cell
density remain negative for LM a2 chain
after 24 h in culture. (C) Mesenchymal
cells allowed to spread for 24 h synthesize
LM a2 chain (red). (D) Epithelial-mesen-
chymal organotypic cocultures. Mesenchy-
mal cells spread around epithelial cell
spheres (e) and express LM a2 (arrow).
The rest of the mesenchymal cells (m)
form a monolayer of round cells and re-
main negative for LM a2. (Inset) Organo-
typic cultures after three days have well
developed epithelial cysts with central lu-
mens. More mesenchymal cells spread
around the cysts and become positive
for LM a2 chain. Bars: (A–D) 15 mm; (in-
set) 60 mm.
Figure 3. LM a2 chain in
round and elongated cells of
the embryonic lung. Western
blot using a polyclonal anti-
body to LM-1/LM-2. Lane 1
(lung R), day 10.5 lungs, con-
taining only round cells.
Lane 2 (lung E), airways and
surrounding mesenchyme
microdissected from day 12
lungs, containing mainly
elongated cells. mes. (lane 3),
peripheral mesenchyme iso-
lated from E12 lungs, containing only round cells (R). Lane 4
(R1), round undifferentiated mesenchymal cells before culture.
Lane 5 (R2), round mesenchymal cells plated at high density to
prevent cell spreading. LM a2 chain is seen only in elongated
cells (lane 2).
Figure 4. Switching cells
from culture conditions pro-
moting rounding or elonga-
tion. Mesenchymal cells cul-
tured on poly-L-lysine (R) or
with poly-L-lysine added to
the culture medium after cell
spreading is completed (E).
After 24 h the cells were re-
plated and cultured for an ad-
ditional 24 h under similar or
opposite conditions. Then
immunoblotting was per-
formed using a polyclonal antibody to LM-1/LM-2. LM a2 band
appears in elongated cells (second and third lane) and is absent in
the round cells (fourth and fifth lane). The first lane is LM-1 from
EHS tumor, used as control.Relan et al. Cell Elongation and Laminin a2: Role in Myogenesis 1345
round and elongated cells (48 6 12 and 50 6 10% of re-
plated cells attached, respectively).
The control of LM a2 chain expression by the cell shape
is not restricted to lung embryonic mesenchymal cells.
During lung development, both epithelial and mesenchy-
mal cells undergo changes in shape. The most dramatic
changes take place on distal epithelial cells that become
totally flat and spread by day 14–15 of gestation. Here we
determined the role of cell shape on lung embryonic epi-
thelial cells as well as on embryonic mesenchymal cells
from kidney and intestine. Immunoblots showed that cell
shape also regulates LM a2 chain expression in these cells
in a similar manner as observed in mesenchymal cells.
Like in embryonic mesenchymal cells, rounding prevented
and spreading induced LM a2 chain synthesis (Fig. 5).
Cell spreading is blocked by monoclonal antibodies to
LM a2 chain. Effect on SM differentiation. In functional
studies, 1 and 2 mg /ml of monoclonal antibody against LM
a2 chain were sufficient to block mesenchymal cell spread-
ing in a statistically significant manner (Fig. 6, A–C).
Higher concentrations of antibody did not further reduce
spreading. Therefore, these studies indicated a reciprocal
interaction between cell shape and LM a2 by showing that
not only is the LM a2 chain induced by cell spreading, but
also that cell spreading is induced by the LM a2 chain.
Mesenchymal cells exposed to the anti-LM a2 chain anti-
bodies showed a decrease in synthesis of SM-specific pro-
teins, including SM a-actin, desmin and myosin when com-
pared with cells exposed to control immunoglobulin (Fig.
6 D, and data not shown). Attachment assays in the pres-
ence of anti-LM a2 chain antibody or IgG control showed
that the antibody also inhibited cell adhesion (64% less
cells attached in the presence of 20 mg/ml of anti-LM a2
chain antibodies than in the presence of same concentra-
tion of control IgG; not shown).
SM cells from adult dy/dy mouse lung spread poorly in
culture and contain less SM-specific protein. Over 40% of
the attached mesenchymal cells, whether isolated from
normal or mutant mice, reacted with anti-desmin antibod-
ies (not shown). All mesenchymal cell cultures isolated
from adult dy/dy mouse lungs showed poor cell spreading
and lower levels of SM-specific protein than controls. The
deficiencies in cell spreading and SM protein synthesis dis-
appeared by plating the cells on LM-2 (Fig. 7). LM-1 or fi-
bronectin coating did not improve the abnormalities in cell
spreading and SM protein synthesis seen in dy/dy mouse
cells (Fig. 7 and data not shown).
Dy/dy mice have SM abnormalities in vivo, including
shorter cells and deficiencies in SM-specific protein pro-
duction. Cell morphometry studies showed that bronchial
SM cells in dy/dy mice were shorter than in control ani-
mals in a statistically significant manner (Fig. 8 A). No dif-
ferences in size were found, however, in lung vascular SM
cells or bronchial columnar epithelial cells (not shown).
Immunoblots demonstrated that adult dy/dy mouse lungs
contained less SM-specific proteins, including SM a-actin,
desmin, and myosin (Fig. 8 B). On histological examina-
tion, the most abnormal SM was that of the trachea and
main bronchi. In those sites, the visceral SM cells were
shorter and underdeveloped (Fig. 9, B and D). For com-
Figure 5. LM a2 chain expression in mesenchymal cells from
other organs and in lung epithelial cells. Western blot using a
polyclonal antibody to LM-1/LM-2 on mesenchymal cells from
day 15 intestine and day 12 kidney, and epithelial cells from day
15 lungs cultured on poly-L-lysine (R) or with poly-L-lysine added
to the culture medium after cell spreading is completed (E). Note
the presence of LM a2 band in elongated cells (E) from all three
sources. The other lanes show b1 and g1 bands only. The first
lane is LM-1 from the EHS tumor, used as control.
Figure 6. Cell spreading per-
turbation assays using anti-
bodies to LM a2 chain. Lung
mesenchymal cells were cul-
tured in the presence of 1 and
2 mg/ml of LM a2 antibody,
IgG control, or 2 mg/ml of
LM  a2 antibody preincu-
bated with LM-2. Cell
spreading was measured af-
ter 24 h in culture. (A) Cells in
the presence of 2 mg/ml IgG.
(B) Cells in the presence of 2
mg/ml LM a2 antibody. (C)
Histogram obtained by mea-
suring the maximal cell diam-
eters under the various treat-
ments. The inhibition in cell spreading was statistically significant, P , 0.0001 for 2 mg/ml LM a2 antibody. (D) Immunoblot showing
less SM a actin in cells exposed to the anti-LM a2 chain antibody. Bar, 40 mm.The Journal of Cell Biology, Volume 147, 1999 1346
parison, A and C show tracheal and bronchial SM in nor-
mal animals of the same strain. Unlike the extraparenchy-
mal airway, the changes in the intraparenchymal bronchial
SM were subtle and detected mainly by cell morphometry
(shorter cells) and immunoblotting as already shown in
Fig. 8. On immunohistochemistry using an anti-SM a-actin
antibody, the large and medium sized bronchial muscle ex-
hibited slightly, but clear thinning and more discontinuity
than the normal counterparts (Fig. 9, E and F).
The SMs of stomach and intestine were also studied.
Histological examination and morphometric studies of the
stomach revealed no alterations in dy/dy mice when com-
pared with controls. The intestine, however, exhibited
shorter SM cells, similar to what was seen in the lung (Fig.
10 A). Unlike the trachea and bronchi, the SM cells in the
intestinal wall were arranged in more layers (hyperplasia)
resulting in a thicker muscularis wall. In the thinnest areas,
the muscular circular layer was 2 6 1-SM cell–thick in dy/dy
mouse intestine and 1 6 1-SM cell–thick in control ani-
mals. In the thickest sites, the circular layer was 15 6 3-cell-
thick in dydy intestine and 12 6 2-cell-thick in controls.
Reflecting this hyperplasia, immunoblotting showed a
slight increase in SM-specific proteins in the intestine of
dy/dy mice compared with controls (Fig. 10 B).
Discussion
Reciprocal Interactions between LM a2 Chain and 
Embryonic Mesenchymal Cell Shape
During development, embryonic cells undergo significant
changes in shape. In the early stages of embryogenesis, es-
sentially all cells are round, but along with differentiation
part of them become spindly whereas others adopt a co-
lumnar, cuboidal, or flat configuration. Our studies (Yang
et al., 1998, 1999) and those of others (Leptin, 1995; Loty
et al., 1995; Anastasi et al., 1997; Fernandez-Valle et al.,
1997; Martin-Blanco, 1997, 1998; Bidwell et al., 1998) indi-
cate that these changes in shape can be part of a mechanis-
tic cascade directing precursor cells to specific differentia-
tion lineages. Among the multiple factors controlling cell
shape, we originally identified LM-1 as relevant for bron-
chial myogenesis (Schuger et al., 1997; Yang et al., 1998).
We observed that during lung development, LM a1 chain
synthesis is induced by epithelial-mesenchymal contact.
LM a1 is deposited at the airway epithelial-mesenchymal
interface, where it stimulates peribronchial mesenchymal
cells to spread and to synthesize SM-specific proteins
(Schuger et al., 1997).
Here we show that this change in cell shape from round
to elongated results in the concomitant induction of LM
a2 chain expression. In these studies we used different cul-
ture approaches to modulate cell shape and to determine
its impact on LM a1, a2, b1, and g1 chain expression. To
confirm our in vitro findings, we analyzed tissue fragments
microdissected from developing lungs containing either
round cells or mostly elongated cells. Our studies demon-
strated that, while LM b1 and g1 chains are equally syn-
thesized by round and elongated cells, LM a2 expression is
under the control of cell shape in such a manner that
round cells do not synthesize LM a2 chain, either in vivo
or in vitro, but its expression is turned on by cell spread-
ing/elongation. Furthermore, the induction of LM a2
chain is a reversible process that can be switched on and
off in culture by cyclic changes in cell shape.
It has been shown that limiting the degree of cell spread-
ing in culture may decrease protein secretion (Singhvi et al.,
1994). In our study, however, LM a2 chain expression was
not suppressed due to nonspecific inhibition in protein
synthesis, as indicated by the fact that round and elon-
gated cells synthesized the same amounts of LM b1/g1
chains. Furthermore, we recently showed that round and
elongated cells cultured on microsurfaces have similar
metabolic rates, and round cells even synthesize higher
levels of a-fetoprotein than their spread/elongated coun-
Figure 7. SM a actin production by lung mesenchymal cells iso-
lated from adult dy/dy mice and controls. Cell spreading and SM
a actin production were determined after 24 h in culture. The his-
togram shows the maximal cell diameters of wild-type and dy/dy
mouse cells cultured on LM-1, LM-2, or uncoated dishes. The im-
munoblot shows SM a actin production by the cells. Notice the
short diameter and low level of SM a actin in dy/dy mouse cells
when cultured on LM-1 or uncoated dishes but not when cul-
tured on LM-2.
Figure 8. SM cell size in intraparenchymal bronchi of dy/dy mice
and controls. (A) Histogram showing maximal nuclear diameter
as an indicator of cell size in hematoxylin eosin-stained histologi-
cal sections of lungs (cell boundaries are not seen in organs). Dy/dy
mice showed shorter nuclei compared with controls (P , 0.05).
(B) Immunoblots demonstrating lower levels of SM proteins in
dy/dy lungs compared with controls.Relan et al. Cell Elongation and Laminin a2: Role in Myogenesis 1347
terparts (Yang et al., 1999). Finally, LM a2 chain was not
found in undifferentiated mesenchyme freshly isolated
from the lungs, confirming its absence in round cells in
vivo.
As previously stressed, among the several LM chains an-
alyzed, the effect of cell shape on message and protein lev-
els was specific to LM a2. Message RNA for LM a1, a4,
a5, b1, and g1 chains was not significantly altered by cyclic
changes in cell shape, neither were LM b1 and g1 polypep-
tide chain levels. In regard to LM a1 chain, its synthesis re-
quires epithelial-mesenchymal cell contact (Schuger et al.,
1997) and as expected it was not detected in fragments of
mesenchyme alone or mesenchymal cell cultures. How-
ever, its presence in the early embryonic lung, where es-
sentially all cells are round, and the lack of significant os-
cillations at the mRNA level (Fig. 1 B), indicated that LM
a1 chain synthesis does not cycle with changes in cell
shape.
Functional studies in which embryonic mesenchymal
cell spreading/elongation was blocked by a monoclonal
antibody against LM a2 chain demonstrated that, once se-
creted, LM a2 chain becomes a powerful stimulus for cell
spreading. The antibody used in our functional studies re-
acts with the NH2-terminal of LM a2 chain, a region that
has been shown to be involved in heparin binding, LM-2
polymerization (Cheng et al., 1997) and cell binding
through integrins a1b1 and a2b1 (Collognato and Yur-
chenco, 1997). The functional role of the NH2 terminus is
also underscored by an animal model of congenital muscu-
lar dystrophy, the dy2J/dy2J mouse. This mutant animal has
a truncated LM a2 chain which lacks only 57 amino acids
at its NH2-terminal domain (Xu et al., 1994a; Sunada et al.,
1995), and nevertheless this deletion is enough to cause
muscular dystrophy. Integrins a1b1 and a2b1 are ex-
pressed by developing bronchial SM (Virtanen et al., 1996;
Wu and Santoro, 1996) and therefore may participate in
LM a2 chain–mediated mesenchymal cell spreading. Sup-
porting such a possibility, deletion of integrin a1 by ho-
mologous recombination permits normal murine develop-
ment but gives rise to specific deficit in mesenchymal cell
adhesion and spreading (Gardner et al., 1996). In addition,
knockout of integrin b1 chain, which cause early embry-
onic death (Fassler and Meyer, 1995), results in retarda-
tion of myogenic differentiation of embryonic stem cells in
culture (Rohwedel et al., 1998).
Figure 9. SM in trachea and bronchi of dy/
dy mice and controls. (A–D) Hematoxylin
eosin-stained histological sections of tra-
chea and main bronchi. (A) Normal tra-
cheal SM (arrows) surrounding tracheal
cartilage; compare to the severely under-
developed tracheal SM in dy/dy mouse,
shown in B (arrows). (C) SM in normal
main bronchus (arrow) is significantly
thicker than in dy/dy mouse (D). (E and
F) intraparenchymal bronchial SM immu-
nostained with antibodies to SM a actin
(brown). (E) Normal SM (arrow) sur-
rounding medium sized bronchi; compare
to thinner, more discontinuous bronchial
muscle in dy/dy mice, shown in F (arrow).
Bars: (A–D) 20 mm; (E and F) 60 mm.
Figure 10. SM cell size in circular layer of intestinal muscularis
propria of dy/dy mice and controls. (A) Histogram showing max-
imal nuclear diameter as an indicator of cell size in hematoxylin
eosin-stained histological sections (cell boundaries are not seen
in organs). Dy/dy mice showed shorter nuclei compared with
controls (P  ,  0.03). (B) Immunoblots demonstrating slightly
higher levels of SM proteins in dy/dy intestine compared with
controls, consistent with the hyperplasia described in Results.The Journal of Cell Biology, Volume 147, 1999 1348
Role of LM a2 Chain in Bronchial Myogenesis
We recently observed that most embryonic mesenchymal
cells are potential SM precursors and if allowed to spread/
elongate, they will differentiate into SM cells (Yang et al.,
1998, 1999). Our functional studies demonstrated that LM
a2 chain deposition in the extracellular matrix is per se a
stimulus for cell spreading. This led us to determine the ef-
fect of inhibiting LM a2 chain–mediated cell spreading on
SM differentiation. Mesenchymal cells exposed to the
anti-LM  a2 chain antibodies showed a decrease in synthe-
sis of SM-specific proteins when compared with controls.
Therefore, a feedback interaction seems to exist between
the cells’ shape, the levels of LM a2 chain and SM myo-
genesis.
The molecular pathways linking LM a2 chain, cell
shape, and SM myogenesis are currently unknown. One
possibility is that by promoting cell spreading/elongation,
LM a2 chain stimulates specific cell receptors known to
function as mechanotransductors, such as integrins (Wang
et al., 1993). These then could activate gene expression by
a signaling mechanism similar to that exerted by the breast
extracellular matrix upon the mammary gland epithelium
(Lelievre et al., 1996). An important player in cell shape
signaling is the Rho family of G proteins (Bussey, 1996).
Interestingly, searching a subtracted cDNA library of un-
differentiated, round mesenchymal cells, we found RhoA
to be highly expressed in round mesenchymal cells
with  minimal expression in elongated cells (Liu, J., and L.
Schuger, unpublished studies). It should be stressed,
however, that cell shape controls gene expression through
multiple mechanisms including signaling pathways not
necessarily involving Rho (Martin-Blanco, 1997, 1998),
changing the cytoskeleton and nuclear matrix architecture
(Loty et al., 1995; Fernandez-Valle et al., 1997; Shannon
et al., 1998; Bidwell et al., 1998), inducing synthesis of
auto/paracrine factors (Vijayakumar et al., 1999), etc.
Therefore, multiple mechanisms may be involved in the
process of LM a2 chain–induced SM myogenesis.
Visceral SM Abnormalities in dy/dy Mice
Dy/dy mice express lower levels of LM a2 chain, due to a
spontaneous genetic mutation (Sunada et al., 1994; Xu et al.,
1994a, 1994b). Therefore, we studied SM cells isolated
from dy/dy lungs to determine how these cells behave in
culture. These mutant mice have been used for many years
as a model of skeletal muscular dystrophy, and although
there are no previous reports describing SM defects in dy/dy
mice, we predicted, based on our findings, that these ani-
mals should have abnormal SM cells. Indeed, we found
that lung SM cells isolated from dy/dy mice spread defec-
tively in culture and synthesize less SM proteins than con-
trols. These deficiencies were overcome by the addition of
exogenous LM-2 but not LM-1 or fibronectin.
On histological examination of lung sections, bronchial
SM cells in dy/dy mice were shorter than in control ani-
mals and their lungs contained less SM-specific proteins.
The morphological abnormalities diminished in severity
from trachea, where the muscle was also underdeveloped,
to the distal bronchi. Although the SM changes in the in-
traparenchymal bronchi were subtle, our current studies
seem to indicate that these are sufficient to affect the elec-
trical and contractile properties of dy/dy SM cells in cul-
ture (Yang, Y., and L. Schuger, ongoing studies). The SM
cells of stomach and intestine were also examined. While
no abnormalities were detected in the former, the intestine
exhibited shorter SM cells, as seen in the bronchi. How-
ever, unlike the airways, the intestinal wall showed more
SM cell layers, indicative of compensatory hyperplasia.
The latter resulted in a net increase of SM-specific pro-
teins in immunoblots.
It is unclear why some SMs were hyperplastic and others
not. One reason could be related to the mechanical chal-
lenge sustained by the muscle. Muscles with peristalsis,
such as the intestine, are rhythmically stimulated to con-
tract. Since SM cells are able to proliferate, the dy/dy
intestinal muscle may overcome the functional deficit
caused by low LM a2 chain with an increment in cell num-
ber, thus, becoming hyperplastic. In contrast, muscles with
minimal mechanical activity, such as the trachea and main
bronchi, experience no mechanical challenge and there-
fore have no need to compensate. Between these two ex-
tremes, SMs with moderate contractile activity, such as the
intraparenchymal bronchi, may require only intermediate
grades of compensation. The gastric and vascular muscula-
ture may also fall under this category.
The Reciprocal Interaction between LM a2 Chain and 
Cell Shape May Play a Role in the Differentiation of 
Other Tissues
The effect of cell shape on LM a2 chain expression was
Figure 11. Proposed role of
LM-1 and LM-2 in bronchial
myogenesis. e, Epithelial
cells (gray); m, mesenchymal
cells (yellow); SM, smooth
muscle cells (from pink to
red); BM, basement mem-
brane. The asterisk tags the
relative position adopted by
an epithelial cell from the
moment it is born and estab-
lishes a new contact with the
mesenchyme.Relan et al. Cell Elongation and Laminin a2: Role in Myogenesis 1349
not restricted to lung mesenchymal cells, but it was seen in
other cells as well. Therefore, our findings suggested that
cell shape–controlled LM a2 chain expression may play a
broader role in development. In this regard, Virtanen et al.
(1996) found that during the preglandular stage of human
lung development, LM a2 chain is deposited in the distal
airway basement membranes, where epithelial cells are
undergoing a change in shape from round/cuboidal to flat/
spread (Burry, 1997). Similarly, Lefebvre et al. (1999)
showed that during intestinal development, LM a2 chain is
synthesized by elongating mesenchymal cells, but not by
epithelial cells that are round/cuboidal in shape. Although
neither of these papers intended to draw correlations be-
tween the cell shape and LM a2 chain expression, both
support the possibility that epithelial cell shape and LM a2
chain may be functionally connected in vivo.
Proposed Roles for LM a1 and a2 in
Bronchial Myogenesis
Fig. 11 depicts the proposed roles of LM a1 and a2 chains
in bronchial myogenesis. Our studies suggest that the de-
velopment of new epithelial-mesenchymal contacts during
lung organogenesis results in the induction of LM a1 chain
expression and deposition of LM-1 at the epithelial/mes-
enchymal interface (Schuger et al., 1997). LM-1 molecules
polymerize, contributing to the formation of a basement
membrane (Schuger et al., 1995, 1998). The mesenchymal
cells apposed to the newly formed basement membrane
utilize this meshwork to spread/elongate through binding
to LM a1 (Schuger et al., 1997). This change in cell shape
induces them to synthesize LM a2 chain and concomi-
tantly to differentiate into SM. Once secreted as part of
LM-2, LM a2 chain stimulates spreading and SM differen-
tiation of nearby mesenchymal cells, eventually leading to
the establishment of a multilayered visceral muscle. The
process of myogenesis could stop when LM a2 chain ex-
pression drops dramatically at the end of the pseudo glan-
dular period (Virtanen et al., 1996) whereby preventing
excessive SM formation.
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